![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Pirmohamed, D Williams, S Madden, E Templeton and BK Park
Department of Pharmacology and Therapeutics, University of Liverpool, UK.
The metabolism of clozapine by human liver has been investigated in vitro. Irreversible protein-binding and conjunction with model nucleophiles have been used as markers for bioactivation of clozapine, while stable metabolite formation has been assessed using radiometric HPLC. In all nine liver microsomal preparations investigated, clozapine was extensively metabolized to the stable products desmethylclozapine (range 19%-27.2%), N-oxide (1.5-20.5%) and three polar metabolites (0- 20.8%), and was bioactivated to a protein-reactive metabolite (0.6- 2.1%). The CYP2D6 genotype did not influence the capacity of the livers to form these metabolites. All metabolic pathways were inhibited by ketoconazole, indicating the involvement of the cytochrome P450 enzymes. Isozyme-selective inhibitor studies demonstrated that whereas demethylation was performed by CYP1A2, N-oxidation and chemically reactive metabolite formation were dependent upon multiple forms of P450. The N-oxide was readily reduced back to clozapine in the presence of NADPH, this conversion being inhibited by ascorbic acid. Glutathione (1 mM) decreased covalent binding by 70%. The amount of putative adduct formed in the presence of glutathione (13.4 +/- 0.9%) was much greater than the covalent binding (mean 1.1 +/- 0.2%). The bioactivation of clozapine was, like the N-oxidation of clozapine, a reversible process. In summary, our results indicate clozapine undergoes extensive metabolism by human liver to both stable and chemically reactive metabolites, the formation of which is catalyzed by the cytochrome P450 enzymes. The role of the reactive metabolite, which may be a free radical, in the pathogenesis of clozapine agranulocytosis and hepatotoxicity requires further study.
This article has been cited by other articles:
|
|
 |
|
  H. Takakusa, H. Masumoto, H. Yukinaga, C. Makino, S. Nakayama, O. Okazaki, and K. Sudo Covalent Binding and Tissue Distribution/Retention Assessment of Drugs Associated with Idiosyncratic Drug Toxicity Drug Metab. Dispos., September 1, 2008; 36(9): 1770 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takakusa, H. Masumoto, A. Mitsuru, O. Okazaki, and K. Sudo Markers of Electrophilic Stress Caused by Chemically Reactive Metabolites in Human Hepatocytes Drug Metab. Dispos., May 1, 2008; 36(5): 816 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kousba, R. Soll, S. Yee, and M. Martin Cyclic Conversion of the Novel Src Kinase Inhibitor [7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-Oxide Metabolite by Flavin-Containing Monoxygenases and Cytochrome P450 Reductase Drug Metab. Dispos., December 1, 2007; 35(12): 2242 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Williams, D. J. Antoine, P. J. Butler, R. Jones, L. Randle, A. Payne, M. Howard, I. Gardner, J. Blagg, and B. K. Park The Metabolism and Toxicity of Furosemide in the Wistar Rat and CD-1 Mouse: a Chemical and Biochemical Definition of the Toxicophore J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1208 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lu and J. P. Uetrecht Possible Bioactivation Pathways of Lamotrigine Drug Metab. Dispos., July 1, 2007; 35(7): 1050 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Coulter, J. Farrell, K. L. Mathews, J. L. Maggs, C. K. Pease, D. J. Lockley, D. A. Basketter, B. K. Park, and D. J. Naisbitt Activation of Human Dendritic Cells by p-Phenylenediamine J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 885 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mori, Y. Maruo, M. Iwai, H. Sato, and Y. Takeuchi UDP-GLUCURONOSYLTRANSFERASE 1A4 POLYMORPHISMS IN A JAPANESE POPULATION AND KINETICS OF CLOZAPINE GLUCURONIDATION Drug Metab. Dispos., May 1, 2005; 33(5): 672 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Wang, Z.-J. Zhang,, W.-B. Li, Y.-M. Zhai, Z.-J. Cai, Y.-Z. Weng, R.-H. Zhu, J.-P. Zhao, and H.-H. Zhou The Differential Effects of Steady-State Fluvoxamine on the Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers J. Clin. Pharmacol., July 1, 2004; 44(7): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Bruce, S. D. Hall, B. D. Haehner-Daniels, and J. C. Gorski In Vivo Effect of Clarithromycin on Multiple Cytochrome P450s Drug Metab. Dispos., July 1, 2001; 29(7): 1023 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schaber, G. Wiatr, H. Wachsmuth, M. Dachtler, K. Albert, I. Gaertner, and U. Breyer-Pfaff Isolation and Identification of Clozapine Metabolites in Patient Urine Drug Metab. Dispos., June 1, 2001; 29(6): 923 - 931. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. P. Williams, M. Pirmohamed, D. J. Naisbitt, J. P. Uetrecht, and B. K. Park Induction of Metabolism-Dependent and -Independent Neutrophil Apoptosis by Clozapine Mol. Pharmacol., July 1, 2000; 58(1): 207 - 216. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. H. Preskorn Debate resolved: there are differential effects of serotonin selective reuptake inhibitors on cytochrome P450 enzymes J Psychopharmacol, January 1, 1998; 12(4_suppl): S89 - S97. [Abstract] [PDF]
|
|
|
|
|
|
K. Linnet and O. V. Olesen Metabolism of Clozapine by cDNA-Expressed Human Cytochrome P450 Enzymes Drug Metab. Dispos., December 1, 1997; 25(12): 1379 - 1382. [Abstract] [Full Text]
|
|
|
|
|
|
D. P. Williams, M. Pirmohamed, D. J. Naisbitt, J. L. Maggs, and B. K. Park Neutrophil Cytotoxicity of the Chemically Reactive Metabolite(s) of Clozapine: Possible Role in Agranulocytosis J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1375 - 1382. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Dain, J. Nicoletti, and F. Ballard Biotransformation of Clozapine in Humans Drug Metab. Dispos., May 1, 1997; 25(5): 603 - 609. [Abstract] [Full Text]
|
|
|
|
|
|
M. Tugnait, E. M. Hawes, G. McKay, A. E. Rettie, R. L. Haining, and K. K. Midha N-Oxygenation of Clozapine by Flavin-Containing Monooxygenase Drug Metab. Dispos., April 1, 1997; 25(4): 524 - 527. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
